Development of a Screening Module to Assess Sibling-Related Psychosocial Risk in Families of Children with Cancer |
Boston University / Kristin Long, PhD |
Psychosocial Grants |
2014 |
Massachusetts |
Blocking the Evil Messenger in MYCN-driven High-risk Neuroblastoma |
Boston University / Hui Feng, Md, PhD |
Innovation Grants |
2022 |
Massachusetts |
Pediatric Oncology Nurses' Experiences with Prognosis-Related Communication |
Marquette University / Amy Newman, RN, MSN |
Nurse Researcher Grants |
2014 |
Wisconsin |
Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma |
University of Virginia, School of Medicine / John Bushweller, PhD |
Innovation Grants |
2015 |
Virginia |
LSD1 Inhibition to Treat T-cell Acute Lymphoblastic Leukemia/Lymphoma |
University of Virginia, School of Medicine / Michael Engel, MD/PhD |
Reach Grants |
2016 |
Virginia |
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma |
Virginia Commonwealth University / Anthony Faber, MD & Yael Mosse, MD (CHOP) |
Innovation Grants |
2015 |
Virginia |
Characterizing Resistance Mechanisms to BET-Bromodomain Inhibition in MYC-amplified |
Broad Institute / Rameen Beroukhim, MD,PhD |
Innovation Grants |
2015 |
Massachusetts |
Mechanisms of BRAF Activation in KIAA1549-BRAF Mutant pLGGs |
Broad Institute / Sean Misek, PhD |
Young Investigator Grants |
2023 |
Massachusetts |
Investigating phase separated condensates in FPD to MDS/AML progression |
Broad Institute / Zuzana Tothova, MD/PhD |
RUNX1 Early Career Investigator Grants |
2019 |
Massachusetts |
Building Capacity for the Clinical Trials Office at Children's Hospital of Wisconsin - Strengthening Phase I & II Trials Infrastructure |
Children's Hospital of Wisconsin - Milwaukee / Michael J. Burke, MD |
Phase I/II Infrastructure Grants |
2015 |
Wisconsin |